Skip to main content

Table 2 Treatment characteristics

From: The effect of tumor volume and its change on survival in stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy

Characteristic

n

(%)

Radiotherapy

  

  3D-CRT

142

(90)

    Median 63 Gy

  

    (59.5–74 Gy/25–37 fractions)

  

  Tomotherapy

12

(8)

    Median 66 Gy

  

    (66–70.4 Gy/27–35 fractions)

  

  IMRT

3

(2)

    60 Gy

  

    (60 Gy/25–30 fractions)

  

Chemotherapy

  

  Cisplatin, Etoposide

54

(34)

  Carboplatin, Paclitaxel

50

(32)

  Cisplatin, Paclitaxel

36

(23)

  Cisplatin, Irinotecan

17

(11)

  1. Abbreviations: 3D-CRT Three-dimensional radiotherapy, IMRT Intensity-modulated radiotherapy.